Cost-benefit analysis of a follow-up program in patients with breast cancer: A randomized prospective study

Breast Journal

Volumn 13, Issue 6, 2007, Pages 571-574

  Oltra, Amparo ^a   Santaballa, A ^b   Munarriz B ^b   Pastor, M ^b   Montalar, J ^b  

^a HOSPITAL VIRGEN DE LOS LIRIOS   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Breast cancer; Cost benefit; Follow up

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RELAPSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BREAST NEOPLASMS; CONFIDENCE INTERVALS; CONTINUITY OF PATIENT CARE; COST-BENEFIT ANALYSIS; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 35748985248     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2007.00506.x     Document Type: Article

References (40)

1. Duffy SW, Tabár L, Chen HH, et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. A collaborative evaluation. Cancer 2002 95 : 458 69.
2. De Koning HJ. Mammographic screening: evidence from randomised controlled trial. Ann Oncol 2003 14 : 1185 9.
3. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005 365 : 1687 717.
4. Goldhirsch A, Colleoni M, Domenighetti G, Gelber RD. Systemic treatments for women with breast cancer: outcome with relation to screening for the disease. Ann Oncol 2003 14 : 1212 4.
5. Tomiak E, Piccart M. Routine follow-up of patients after primary therapy for early breast cancer: changing concepts and challenges for the future. Ann Oncol 1993 4 : 199 204.
6. Mapelli V, Dirindin N, Grilli R. Economic evaluation of diagnostic follow-up after primary treatment for breast cancer. Results of the Working Group on Economic-Organizational Aspects of follow-up. Ann Oncol 1995 6 (Suppl. 2 61 4.
7. Grundfeld E, Gray A, Mant D, et al. Follow up of breast cancer in primary care vs specialist care: results of an economic evaluation. Br J Cancer 1999 79 : 1227 33.
8. Mille D, Ray T, Carrére MO, et al. Economic impact of harmonizing medical practices: compliance with clinical practice guidelines in the follow-up of breast cancer in French Comprehensive Cancer Center. J Clin Oncol 2000 18 : 1718 24.
9. Schapira DV. Breast cancer surveillance - a cost-effective strategy. Br Cancer Res Treat 1993 25 : 107 11.
10. Roselli del Turco M, Palli D, Caridi A, et al. Intensive follow-up after treatment of primary breast cancer. A randomized trial. JAMA 1994 271 : 1593 7.
11. GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994 271 : 1587 92.
12. Palli D, Russo A, Saieva C, et al. Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of randomized trial. JAMA 1999 281 : 1586.
13. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 5th edition. Philadelphia, PA : Lippincot-Raven, 1997 : 171 80.
14. Emens LA, Davidson NE. The follow-up of breast cancer. Semin Oncol 2003 30 : 338 48.
15. Jemel A, Murray T, Samuels A, et al. Cancer Statistics, 2003. CA Cancer J Clin 2003 53 : 5 26.
16. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-1999). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April, 2002 based on the November 2001 submission.
17. Wheeler T, Stenning S, Negus S, Picken S, Metcalfe S. Evidence to support a change in follow-up policy for patients with breast cancer: time to first relapse and hazard rate analysis. Clin Oncol 1999 11 : 169 73.
18. Loprinzi CL, Hayes D, Smith T. Doc shouldn't we be gettin some tests? J Clin Oncol 2003 21 (Suppl. 9 108 11.
19. Kattlove H, Winn RJ. Ongoing care of patient after primary treatment of their cancer. Cancer J Clin 2003 53 : 172 96.
20. Schapira DV, Urban N. A minimalist policy for breast cancer surveillance. J Am Med Assoc 1991 265 : 380 2.
21. Cady B. Cost-effective preoperative evaluation, operative treatment and postoperative follow-up in the breast cancer patients. Surg Clin North Am 1996 76 : 25 34.
22. Joseph E, Hyacinthe M, Lyman GH, et al. Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol 1998 5 : 522 8.
23. Jacobs HJ, Van Dijick JAAM, de Kleijin, Kiemeney LALM, Verbeek ALM. Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: a simulation study. Ann Oncol 2001 12 : 1107 13.
24. Churn M, Kelly V. Outpatient follow-up after treatment for early breast cancer: updated results after 5 years. Clin Oncol (R Coll Radiol) 2001 13 : 187 94.
25. Ormiston MC, Timoney AG, Quereshi AR. Is follow up of patients after surgery for breast cancer worthwhile? J Roy Soc Med 1985 78 : 920 1.
26. Hannisdal E, Gundersen S, Kvalov S, et al. Follow-up of breast cancer patients stage I-II: a baseline strategy. Eur J Cancer 1993 29 : 992 7.
27. Grunfeld E, Mant D, Patricia Y, et al. Follow up of breast cancer. Routine follow up of breast cancer in primary care: randomised trial. Br Med J 1996 313 : 665 9.
28. Loong S, Wilkins H, Bliss JM, et al. The effectiveness of the routine clinic visit in the follow-up breast cancer patients: analysis of a defined patient cohort. Clin Oncol 1998 10 : 103 6.
29. Pivot X, Asmar L, Hortobagy GN, et al. A retrospective study of first indicators of breast cancer recurrence. Oncol 2000 58 : 185 90.
30. Boekhorst DS, Peer NG, Van der Sluis RF, Wobbes T, Ruers TJ. Periodic follow-up after Breast Cancer and the effect on survival. Eur J Surg 2001 167 : 490 6.
31. Donnely J, Mack P, Donaldson LA. Follow-up of breast cancer time for new approach? Int J Clin Pract 2001 55 : 431 3.
32. Prager D, Grundfest S, Lerner HJ, et al. Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy. Semin Oncol 1995 22 : 13 31.
33. American Society of Clinical Oncology. Recommended breast cancer surveillance guidelines. J Clin Oncol 1997 15 : 2149 56.
34. Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999 17 : 1080 2.
35. Bast RC, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 19 : 1865 78.
36. Brown L, Payne S, Royle G. Patient initiated follow up of breast cancer. Psychooncology 2002 11 : 346 55.
37. Rojas MP, Telaro E, Russo A, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 2000 4 : CD001768.
38. Fehm T, Gebauer G, Jager W. Clinical utility of serial serum c-erbB-2 determination in the follow-up of breast cancer. Breast Cancer Res Treat 2002 75 : 97 106.
39. Wu D, Gambhir SS. Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives. Clin Breast Cancer 2003 4 (Suppl. 1 S55 63.
40. Kionberg IL, Holmberg L, Fridlund B. Satisfaction with routine follow-up visits to the physician. Acta Oncol 2001 40 : 454 9.